

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Abortion providers in North Carolina and SisterSong Women of Color Reproductive Justice Collective sued today challenging several medically unnecessary abortion restrictions that have pushed abortion out of reach in the state and stigmatized essential health care. The lawsuit was filed by the American Civil Liberties Union, the ACLU of North Carolina, Planned Parenthood Federation of America, and the Center for Reproductive Rights.
Decades of attacks on reproductive rights and health care access by state legislators have already led to provider shortages and an inadequate public health infrastructure in the state, with the COVID-19 pandemic only exacerbating these issues. These discriminatory policies violate civil and reproductive rights, and disproportionately impact North Carolina's communities of color, particularly Black communities, as well as rural communities.
The restrictions being challenged include:
The groups issued the following statements:
Statement from Anjali Dalal, senior staff attorney, ACLU Reproductive Freedom Project:
"Since 2011, politicians have passed more than 460 medically unnecessary laws to push abortion out of reach. The laws we are challenging today create a web of restrictions that limit whether, when, and under what circumstances people may obtain an abortion. They serve only as obstacles in the way of needed medical care, and should be struck down to ensure North Carolinians can access abortion, and ensure pateints from surrounding states, that are increasingly hostile to abortion, can do the same."
Statement from Monica Simpson, executive director, SisterSong Women of Color Reproductive Justice Collective:
"For true reproductive freedom, we need far more than the legal right to abortion. If we are not able to get reproductive health care when we need it, from providers we trust, in spaces that are accessible and affirming to our communities and our needs, then we are not actually free. As a North Carolina native, I've seen firsthand how these laws insult the dignity and humanity of Black and brown women, trans, and non-binary folks; we have been denied full access to reproductive justice for far too long. SisterSong joins this lawsuit as a continuation of our communities' deep and ongoing leadership in North Carolina and across the South. We know we will see the end of racist, misogynist abortion laws in this state."
Statement from Elizabeth Barber, reproductive freedom fellow at the ACLU of North Carolina:
"People aren't truly free if we can't make our own decisions about our bodies, our lives, and our futures. Access to healthcare should be safe, affordable, and free from government interference. We are hopeful that the court will uphold the basic rights of North Carolinians by removing barriers that currently restrict access to safe reproductive healthcare and tie the hands of medical professionals who should be free to provide the best care for their patients."
Statement from Alexis McGill Johnson, president and CEO, Planned Parenthood Federation of America:
"For decades, the reproductive rights of North Carolinians have been relentlessly attacked by politicians in the state legislature who have created a complex web of medically unnecessary requirements designed to push abortion access out of reach. Today, our nation is also facing dueling, emergent public health crises: state-sanctioned racist violence against people of color and COVID-19. The lawsuit filed today in North Carolina is one piece of our fight to ensure patients can access essential health care, including vital family planning services -- regardless of who they are or where they live."
Statement from Nancy Northup, president & CEO of the Center for Reproductive Rights:
"These laws do nothing but make it harder to access abortion and should be struck down. North Carolina legislators should be expanding access to health care, not restricting it. This is particularly important during a pandemic. That means expanding the use of telehealth and getting rid of needless barriers that serve no medical purpose."
Access to abortion is limited in North Carolina as a result of decades of political attacks that reached a fever pitch under former Gov. Pat McCrory. During the McCrory-Forest administration, 11 abortion facilities were shut down, leaving 91 percent of North Carolina counties without an abortion provider and disproportionately hurting rural communities. And politicians showed they'd stop at nothing to chip away at abortion access even further. Then-Speaker of the House Thom Tillis infamously added numerous abortion restrictions into a motorcycle safety bill as a backdoor attempt to quietly erode reproductive rights on the final day of the 2013 legislative session.
The plaintiffs in the case are Planned Parenthood South Atlantic; SisterSong; A Woman's Choice of Charlotte, Inc.; A Woman's Choice of Greensboro, Inc.; A Woman's Choice of Raleigh, Inc; three doctors; and one advanced practice clinician. They are represented by Planned Parenthood Federation of America, the American Civil Liberties Union (ACLU), the ACLU of North Carolina, and the Center for Reproductive Rights.
The American Civil Liberties Union was founded in 1920 and is our nation's guardian of liberty. The ACLU works in the courts, legislatures and communities to defend and preserve the individual rights and liberties guaranteed to all people in this country by the Constitution and laws of the United States.
(212) 549-2666"The truth is, there are not enough factories, or skilled workers, or materials to effectively spend such a huge increase," said one expert. "It will be a recipe for waste, fraud, and abuse."
The budget document that President Donald Trump's White House is set to release Friday calls for $1.5 trillion in military spending for the coming fiscal year, an unprecedented sum that—if approved by Congress—would add nearly $7 trillion to the US national debt over the next decade.
The Wall Street Journal's editorial board, which got an early look at the president's fiscal year 2027 budget, reported that the plan includes roughly $1.15 trillion in baseline US military spending as well as $350 billion in supplemental funding "that Republicans could pass in a party-line budget reconciliation bill." The Journal doesn't specify the purpose of the proposed supplemental funding, but the Pentagon has asked Congress for at least $200 billion for the Iran war.
The budget, which would boost total US military spending by more than 40% compared to the current fiscal year, also reportedly calls for investments in Trump's so-called Golden Dome missile defense system, a project that critics have derided as an absurd boondoggle.
Earlier this week, Trump suggested the US federal government can't afford to fund childcare and other domestic social programs because it is "fighting wars."
William Hartung, a senior research fellow at the Quincy Institute for Responsible Statecraft, wrote in an analysis of the budget proposal ahead of its official release that "whatever vehicles the administration chooses to promote this huge increase, it will be doubling down on a failed budgetary and national security strategy."
"If passed as requested, $1.5 trillion in Pentagon spending—in a single year–will make America weaker by underwriting a misguided strategy, funding outmoded weapons programs, and crowding out other essential public investments," Hartung argued. "The Pentagon doesn’t need more spending, it needs more spending discipline. Spending billions of dollars on a Golden Dome system that can never achieve the President’s dream of a leak-proof missile defense system is sheer waste, as is continuing to lavish funds on overpriced, underperforming combat aircraft like the F-35, or multi-billion dollar aircraft carriers that are vulnerable to modern high-speed missiles."
"The truth is, there are not enough factories, or skilled workers, or materials to effectively spend such a huge increase," he added. "It will be a recipe for waste, fraud, and abuse."
In anticipation of the White House proposal, a broad coalition of nearly 300 advocacy organizations sent a letter to members of Congress on Thursday demanding that they reject Trump's request and any other proposed budget increases for the Pentagon, which recently failed its eighth consecutive audit.
"We must invest in critical human needs programs in our communities. Instead, we have cut those programs massively," the groups wrote, pointing to the record Medicaid and nutrition assistance cuts that Trump and congressional Republicans approved last year.
"The Pentagon is unaccountable to American taxpayers, having never passed an audit, while more than half of its budget (54 percent) is paid to corporate military contractors, whose profits are rising. Further gigantic increases would be grossly irresponsible," the groups continued. "Funding an unaccountable Pentagon by more than $1 trillion while underfunding human needs programs undermines our security by preventing us from investing in the shared prosperity that comes from more housing, health care, climate and public health protections, ending hunger, and providing quality public education."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," one analyst wrote of the Trump administration's assault.
US President Donald Trump late Thursday threatened more illegal attacks on Iranian civilian infrastructure, including bridges and power plants, as Iran's military said it shot down an American fighter jet over Tehran, with state-affiliated media publishing apparent photos from the scene.
An Iranian official told Drop Site's Jeremy Scahill that Iran's forces hit an F-15 warplane, causing the jet to crash and sparking "an intense fire." The unnamed Iranian official said the pilot could not have evacuated due to the "nature of the strike," but "no remains have yet been found."
The US Central Command had not commented on the purported downing of an American fighter jet as of this writing. Last month, a US F-35 was forced to make an emergency landing at an air base in the Middle East after reportedly being struck by Iranian fire.
🚨 BREAKING | An Iranian official told Drop Site News that a U.S. F-15 warplane struck by Iranian forces went down over southern Tehran Province, with intense fire reported at the crash site.
The official said the nature of the strike prevented the pilot[s] from ejecting before… https://t.co/iUKD0AqRQQ pic.twitter.com/BI4TzolmZY
— Drop Site (@DropSiteNews) April 3, 2026
Iran's claim on Friday came as Trump issued more belligerent threats on his social media platform, declaring that the US military "hasn’t even started destroying what’s left in Iran."
"Bridges next, then Electric Power Plants!" the president wrote, shortly after bragging about the US military's destruction of an Iranian highway bridge. "New Regime leadership knows what has to be done, and has to be done, FAST!"
Brian Finucane, senior adviser to the US Program at the International Crisis Group, characterized Trump's message as "more threats of war crimes as POTUS flails and seeks to coerce an exit to his own self-inflicted, unnecessary, and ill-conceived war."
Trump's renewed threats came amid reports of US-Israeli attacks on a century-old Iranian medical research center, pharmaceutical facilities, residential buildings, and other civilian infrastructure—and on emergency responders aiding those wounded by the attacks.
"War crime after war crime after war crime," US Rep. Yassamin Ansari (D-Ariz.), the lone Iranian American member of Congress, wrote early Friday. "Now’s the time to speak up if you’re against this reckless war of choice. The consequences will be vast and catastrophic."
Ben Rhodes, a political analyst who worked in the Obama administration, wrote that the US military's recent actions have "nothing to do with nuclear or helping Iranians."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," Rhodes added.
One campaigner urged the administration to "focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
On Thursday, the one-year anniversary of President Donald Trump's so-called Liberation Day, US advocacy groups sounded the alarm about his new tariffs targeting "patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 to bolster American national security and public health."
The administration announced a year ago that the US Department of Commerce would conduct a related investigation under that law. The resulting report was recently sent to the president, and although the findings have not been made public, Trump's executive order summarizes key takeaways and Secretary Howard Lutnick's recommended actions.
According to the order, the secretary's recommendations included "continuing to negotiate onshoring agreements related to most favored nation (MFN) pharmaceutical pricing agreements; imposing significant tariffs on pharmaceuticals and pharmaceutical ingredients, so that such imports will not threaten to impair the national security of the United States; and granting preferential treatment to those companies that commit to onshore production of pharmaceuticals and pharmaceutical ingredients."
Citing an unnamed Trump administration official, The Washington Post reported Thursday that "the White House has reached agreements with 13 drugmakers and expects to soon conclude an additional four." As part of these deals, companies are planning to invest at least $400 billion in new US plants.
The Post also pointed out that "some imported drugs will face much lower tariffs under trade deals Trump negotiated with five US trading partners. Goods from the European Union, Japan, South Korea, and Switzerland will face 15% levies, while drugs from the United Kingdom, which was the first to sign a deal with Trump, will be hit with a 10% tariff."
Thanks to Trump's new order, brand-name pharmaceuticals made in other countries could be hit with tariffs as high as 100%.
Merith Basey, CEO of Patients for Affordable Drugs, warned in a statement that "while these tariffs aim to pressure pharmaceutical corporations into US manufacturing and most favored nation agreements, the current MFN deals remain opaque and voluntary, and have not delivered meaningful savings for the vast majority of American patients. There's a real risk these tariffs will drive up costs and create more uncertainty for millions of patients already struggling to afford their medications."
Experts at Public Citizen, another advocacy group that has sued to expose the secretive MFN agreements, were similarly critical.
"By announcing these tariffs without even producing the evidence from the investigation that supposedly justifies them, Trump is continuing his pattern of grabbing headlines by using the word 'tariff' while engaging in secretive ongoing negotiations and opaque exemptions processes that are ripe for corporate corruption," said Public Citizen Global Trade Watch director Melinda St. Louis—who also wrote a broader takedown of Trump's trade policy published Thursday by Common Dreams.
"While strategic tariffs can be used to support domestic manufacturing and good jobs, they must be paired with real public investments and support for workers' rights, which Trump has systematically undermined," she said. "Instead, he's bullying other countries like the UK into paying more for medicines, which will lead to windfall profits for Big Pharma and do nothing to reduce US prices."
Peter Maybarduk, director of Access to Medicines at Public Citizen, stressed that "Trump's tariffs will be either ineffective or harmful for what people need, which is a reliable, plentiful, affordable supply of medicine."
Also taking aim at the "secretive arrangements that allow Trump to claim specious victories on manufacturing and high drug prices," Maybarduk explained that "in reality, many manufacturing commitments claimed under the deals were part of previously planned projects and the drug pricing commitments appear designed to largely spare drug company profits rather than earnestly address affordability concerns."
"Meanwhile the administration has given drugmakers perks like lucrative vouchers to accelerate FDA review of their medicines and a promise from the Trump administration that it will bully other countries into adopting higher prescription drug prices, using tariffs as leverage," he continued, referring to the Food and Drug administration.
"If the administration wants to fix problems like medicines shortages and fragile supply chains," he argued, "it should focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."